Aadi Bioscience (AADI) Revenue & Revenue Breakdown
Aadi Bioscience Revenue Highlights
Latest Revenue (Y)
$24.35M
Latest Revenue (Q)
$7.21M
Main Segment (Y)
Product
Aadi Bioscience Revenue by Period
Aadi Bioscience Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $24.35M | 60.06% |
2022-12-31 | $15.22M | 1421.60% |
2021-12-31 | $1.00M | -92.86% |
2020-12-31 | $14.00M | 1769.16% |
2019-12-31 | $749.00K | -96.28% |
2018-12-31 | $20.16M | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | - |
Aadi Bioscience Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $7.21M | 16.72% |
2024-06-30 | $6.18M | 15.43% |
2024-03-31 | $5.35M | -15.38% |
2023-12-31 | $6.33M | 6.16% |
2023-09-30 | $5.96M | -3.92% |
2023-06-30 | $6.20M | 5.71% |
2023-03-31 | $5.87M | 12.24% |
2022-12-31 | $5.23M | 23.13% |
2022-09-30 | $4.25M | 23.51% |
2022-06-30 | $3.44M | 48.98% |
2022-03-31 | $2.31M | 130.70% |
2021-12-31 | $1.00M | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | -100.00% |
2021-03-31 | $120.00K | -99.14% |
2020-12-31 | $14.00M | 5960.61% |
2020-09-30 | $231.00K | 158.43% |
2020-06-30 | $89.39K | -19.15% |
2020-03-31 | $110.56K | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $2.14K | -99.99% |
2018-09-30 | $18.82M | 1311.65% |
2018-06-30 | $1.33M | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | - |
Aadi Bioscience Revenue Breakdown
Aadi Bioscience Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 19 | Dec 18 |
---|---|---|---|---|---|
Product | $24.35M | $15.22M | - | - | - |
License | - | - | $1.00M | $20.00M | $20.00M |
Grant | - | - | $120.00K | - | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Sep 18 | Jun 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $7.21M | $5.35M | $6.33M | $5.96M | $6.20M | $5.87M | $5.23M | $4.25M | $3.44M | $2.31M | - | - | - |
Grant | - | - | - | - | - | - | - | - | - | $120.00K | - | - | - |
License | - | - | - | - | - | - | - | - | - | - | - | $18.70M | $1.30M |
Latest
Aadi Bioscience Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical | $434.25M | $147.03M |
ARVN | Arvinas | $78.50M | $102.40M |
AADI | Aadi Bioscience | $24.35M | $7.21M |
ADAG | Adagene | $18.11M | $833.34K |
ANAB | AnaptysBio | $17.16M | $30.02M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
CRNX | Crinetics Pharmaceuticals | $4.01M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
DSGN | Design Therapeutics | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
AVTE | Aerovate Therapeutics | - | - |
KURA | Kura Oncology | - | - |
ERAS | Erasca | - | - |
ACRV | Acrivon Therapeutics | - | - |
MLYS | Mineralys Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |